Table 4. Characteristics of the BMT procedure and its related complications.
Patient | Donor | Year of BMT | Age at BMT (month) | Follow-up (months) | Conditioning | Graft | Prophylaxis | Neutrophils (days) | Acute GVHD | Febrile episodes |
P1 | MMRD | 2005 | 4 | 36 | No | PBSC/CD34 | No | 25 | grade IV | 2 |
P2 | MMRD | 20052006 | 47 | 22 | No | PBSC/CD34 | No | 28 | grade IV | 2 |
P3 | MRD | 1998 | 7.5 | 146 | No | BM | No | 13 | No | 1 |
P4 | MMRD | 2002 | 4 | 92 | No | PBSC/CD34 | No | 10 | No | 0 |
P5 | MMRD | 2000 | 1.5 | 132 | No | PBSC/CD34 | No | 10 | grade III | 2 |
P6 | MRD | 2000 | 1 | 119 | No | BM | No | 11 | No | 1 |
P7 | MMRD | 1997 | 5 | 150 | Bu Cy ATG | PBSC/CD34 | CSA | 8 | grade III | 2 |
P8 | MRD | 2008 | 7.5 | 25 | Tre Flu Thi | BM | CSA+MTX | 15 | grade II | 1 |
P9 | MUD | 2010 | 5 | 4 | Bu Cy ATG | UCB | CSA | 13 | grade I | 1 |
P10 | MMRD | 2009 | 5 | 9 | Flu, Mel, Thi OKT3 | PBSC/CD34 | MMF | 9 | No | 2 |
MRD - match related donors, MUD - match unrelated donor, MMRD - mismatch related donor, Bu – Busulfan, Cy – cyclophosphamide, ATG – anti thymocytes globulin, Tre – Treosulfan, Flu – Fludarabine, Thi – Thiotepa, Mel – melphalan, PBSC –peripheral blood stem cells, BM – Bone marrow, UCB – Umbilical cord blood, CSA – Cyclosporin, MTX – methotrexate, MMF – mycophenolate mofetil.